US stock futures higher after Meta, Microsoft results
Both companies are part of the so-called Magnificent Seven megacap, influential tech giants. After reporting strong results, Microsoft shares rose to push the software giant's valuation passed the $4 trillon mark. The only other company that has achieved that is chip maker Nvidia, which did earlier this month to become the first company ever to top $4 trillion.
At 6:10 a.m. ET, futures tied to the blue-chip Dow added 0.33%, broad S&P 500 futures rose 0.95% and tech-heavy Nasdaq futures climbed 1.28%.
More earnings are on tap. Comcast, Bristol-Myers Squibb, Cigna, CVS Health, Shake Shack, AbbVie and Mastercard are among the companies set to report earnings before the opening bell. Results from Apple and Amazon are due in the afternoon.
More trade deals
Some countries are scrambling to strike a trade deal by the Aug 1 deadline coming soon.
South Korea agreed to a 15% tax on the country's incoming goods into the United States.
Commerce Secretary Howard Lutnick also said deals were made with Cambodia and Thailand.
President Donald Trump and his Mexican counterpart Claudia Sheinbaum plan to talk about tariffs.
Corporate news
Medora Lee is a money, markets, and personal finance reporter at USA TODAY. You can reach her at mjlee@usatoday.com and subscribe to our free Daily Money newsletter for personal finance tips and business news every Monday through Friday.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Washington Post
26 minutes ago
- Washington Post
Economic fears of investors are here — and fed by Trump's reaction
For months, the U.S. economy appeared to be weathering the disruptive effects of President Donald Trump's trade and immigration policies. But over the course of 72 hours, that sunny outlook darkened, as the latest government data this week showed the president's revolutionary remaking of the world's largest economy had hit a snag.
Business Insider
an hour ago
- Business Insider
J.P. Morgan Sticks to Its Hold Rating for SoFi (SOFI)
J.P. Morgan analyst Reginald Smith maintained a Hold rating on SoFi on July 30 and set a price target of $22.00. The company's shares closed yesterday at $21.23. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. According to TipRanks, Smith is a 4-star analyst with an average return of 11.8% and a 51.00% success rate. Smith covers the Financial sector, focusing on stocks such as Riot Platforms, Marathon Digital Holdings, and Cleanspark. In addition to J.P. Morgan, SoFi also received a Hold from Redburn Atlantic's Harry Bartlett in a report issued yesterday. However, on July 31, Mizuho Securities maintained a Buy rating on SoFi (NASDAQ: SOFI). SOFI market cap is currently $25.17B and has a P/E ratio of 43.04. Based on the recent corporate insider activity of 60 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of SOFI in relation to earlier this year. Most recently, in June 2025, Magdalena Yesil, a Director at SOFI sold 174,280.00 shares for a total of $2,469,547.60.
Business Insider
an hour ago
- Business Insider
J.P. Morgan Keeps Their Buy Rating on Merit Medical Systems (MMSI)
J.P. Morgan analyst Robbie Marcus maintained a Buy rating on Merit Medical Systems on July 31 and set a price target of $95.00. The company's shares closed yesterday at $84.78. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Marcus covers the Healthcare sector, focusing on stocks such as Medtronic, Edwards Lifesciences, and Baxter International. According to TipRanks, Marcus has an average return of 8.8% and a 52.81% success rate on recommended stocks. In addition to J.P. Morgan, Merit Medical Systems also received a Buy from Needham's Michael Matson in a report issued on July 31. However, yesterday, TR | OpenAI – 4o reiterated a Hold rating on Merit Medical Systems (NASDAQ: MMSI). The company has a one-year high of $111.45 and a one-year low of $81.04. Currently, Merit Medical Systems has an average volume of 657.7K. Based on the recent corporate insider activity of 50 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of MMSI in relation to earlier this year. Most recently, in June 2025, Raul Jr. Parra, the CFO & Treasurer of MMSI sold 15,181.00 shares for a total of $1,423,218.75.
